You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
耀才团队: 市场转为关注中国CPI及PPI
阿思达克 12-09 11:00
耀才证券研究部团队称,隔晚(8日)美股三大指数全线向上,并一同创出纪录新高,英国启动新冠肺炎疫苗大规模施打计画,为全球首次采用辉瑞(PFE.US)及BionTech(BNTX.US)的疫苗;道指高见30,246点创历史新高;纳指连升第四日,收报12,582点创收市新高;标指收跌7点;标普500指数亦创新高,收报3,702点。港股ADR及黑期预示恒指将反弹过百点,但仍可能受制於20天线,中国与美澳关系紧张,市场将焦点转为内地经济数据,市场预计CPI按年升幅持平,PPI则按年下跌1.8%。

京东健康(06618.HK)昨日首挂表现亮丽,MSCI将把其纳入MSCI标准指数及大盘股指数,本月22日起生效,而富时罗素的富时香港指数亦会纳入京东健康,本月21日起生效,将会有更多被动资金追入。

从技术上看,恒指短线跌穿即市支持20天线,该水平同时为保力加通道之中轴,假若未能修复该水平恒指将下试通道底部26,132点,即需要修补11月16号造成的上升裂口。如果成功重反20天线,即有望於27,000点前作上落格局。

(笔者为证监会持牌人)~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account